Preclinical News and Research

RSS
Cannabis Science commences CSTATI-1 preclinical studies in Squamous/BCCs, Kaposi's sarcoma

Cannabis Science commences CSTATI-1 preclinical studies in Squamous/BCCs, Kaposi's sarcoma

Sleep medicine and research: an interview with James K. Walsh

Sleep medicine and research: an interview with James K. Walsh

Bruker to purchase preclinical imaging product portfolio and related assets from Carestream

Bruker to purchase preclinical imaging product portfolio and related assets from Carestream

Case Western Reserve researcher to identify mechanistic link between psoriasis and CVD

Case Western Reserve researcher to identify mechanistic link between psoriasis and CVD

MD Anderson introduces Moon Shots Program to reduce cancer deaths

MD Anderson introduces Moon Shots Program to reduce cancer deaths

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Enrollment complete in Gamida Cell’s NiCord Phase I/II trial for hematological malignancies

Enrollment complete in Gamida Cell’s NiCord Phase I/II trial for hematological malignancies

Oxygen Biotherapeutics first quarter net loss increases to $3.6 million

Oxygen Biotherapeutics first quarter net loss increases to $3.6 million

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

Positive data from Nektar’s NKTR-192 Phase 1a study on acute pain

ProImmune launches ProStorm in vitro cytokine release assay

ProImmune launches ProStorm in vitro cytokine release assay

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

UCSF-led research team targets physiological factors that lead to asthma attack

UCSF-led research team targets physiological factors that lead to asthma attack

Novel drug combination for patients with NRAS-mutant melanoma

Novel drug combination for patients with NRAS-mutant melanoma

UMass Amherst develops 'chemical nose' array to detect metastatic cancers

UMass Amherst develops 'chemical nose' array to detect metastatic cancers

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

HSS receives NFL grant for research into platelet-rich plasma and stem cells

HSS receives NFL grant for research into platelet-rich plasma and stem cells

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Oxyphenbutazone can kill drug resistant TB

Oxyphenbutazone can kill drug resistant TB

Annovation Biopharma to develop novel anesthetics with $8M Series A financing

Annovation Biopharma to develop novel anesthetics with $8M Series A financing

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

Data from BioLineRx’s BL-7010 pre-clinical studies on celiac disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.